Matches in SemOpenAlex for { <https://semopenalex.org/work/W2314619188> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- W2314619188 endingPage "9" @default.
- W2314619188 startingPage "9" @default.
- W2314619188 abstract "With the launch of an independent joint venture called Regulus Therapeutics, Isis Pharmaceuticals and Alnylam Pharmaceuticals hope to become a force in the emerging field of therapeutics that target microRNAs. Both firms will contribute intellectual property, technology, and expertise in microRNAs to Regulus, and Alnylam will lay out $10 million in initial funding. Future funding will come equally from Isis and Alnylam. MicroRNAs are small, single-stranded RNAs that are about 20 nucleotides in length. They serve as the gatekeepers for messenger RNAs, regulating mRNAs' ability to relay the instructions for protein production to their intended targets. The roughly 500 microRNAs that have been identified are believed to regulate expression of one-third of all human genes, according to Isis CEO Stanley Crooke. The ubiquity of microRNAs, as well as their ability to broadly modulate disease, has quickly made them an intriguing therapeutic target. Antagonism of microRNA defines a new strategy to ..." @default.
- W2314619188 created "2016-06-24" @default.
- W2314619188 creator A5033782239 @default.
- W2314619188 date "2007-09-17" @default.
- W2314619188 modified "2023-09-25" @default.
- W2314619188 title "BIOTECHNOLOGY Isis and Alnylam joint venture will capitalize on microRNA expertise" @default.
- W2314619188 doi "https://doi.org/10.1021/cen-v085n038.p009a" @default.
- W2314619188 hasPublicationYear "2007" @default.
- W2314619188 type Work @default.
- W2314619188 sameAs 2314619188 @default.
- W2314619188 citedByCount "0" @default.
- W2314619188 crossrefType "journal-article" @default.
- W2314619188 hasAuthorship W2314619188A5033782239 @default.
- W2314619188 hasConcept C110354214 @default.
- W2314619188 hasConcept C127413603 @default.
- W2314619188 hasConcept C144133560 @default.
- W2314619188 hasConcept C170154142 @default.
- W2314619188 hasConcept C178550888 @default.
- W2314619188 hasConcept C18555067 @default.
- W2314619188 hasConcept C2983292776 @default.
- W2314619188 hasConceptScore W2314619188C110354214 @default.
- W2314619188 hasConceptScore W2314619188C127413603 @default.
- W2314619188 hasConceptScore W2314619188C144133560 @default.
- W2314619188 hasConceptScore W2314619188C170154142 @default.
- W2314619188 hasConceptScore W2314619188C178550888 @default.
- W2314619188 hasConceptScore W2314619188C18555067 @default.
- W2314619188 hasConceptScore W2314619188C2983292776 @default.
- W2314619188 hasIssue "38" @default.
- W2314619188 hasLocation W23146191881 @default.
- W2314619188 hasOpenAccess W2314619188 @default.
- W2314619188 hasPrimaryLocation W23146191881 @default.
- W2314619188 hasRelatedWork W1506218121 @default.
- W2314619188 hasRelatedWork W1866502245 @default.
- W2314619188 hasRelatedWork W1953006176 @default.
- W2314619188 hasRelatedWork W2051829196 @default.
- W2314619188 hasRelatedWork W2073924382 @default.
- W2314619188 hasRelatedWork W2096973171 @default.
- W2314619188 hasRelatedWork W2571468555 @default.
- W2314619188 hasRelatedWork W3148117439 @default.
- W2314619188 hasRelatedWork W365832413 @default.
- W2314619188 hasRelatedWork W4245042867 @default.
- W2314619188 hasVolume "85" @default.
- W2314619188 isParatext "false" @default.
- W2314619188 isRetracted "false" @default.
- W2314619188 magId "2314619188" @default.
- W2314619188 workType "article" @default.